Influence of Hypovolemia on the Pharmacokinetics and the Electroencephalographic Effect of Etomidate in the Rat1

Abstract

The influence of hypovolemia (removal of 30% of the blood volume) on the pharmacokinetics and pharmacodynamics of etomidate was investigated in the rat. Chronically instrumented animals were randomly allocated to either a control (n = 9) or a hypovolemia (n = 9) group, and etomidate was infused (50 mg/kg/h) until isoelectric periods of 5 s or longer were observed in the electroencephalogram. The changes observed in the electroencephalogram were quantified using aperiodic analysis in the 2.5- to 7.5-Hz frequency band and used as a surrogate measure of hypnosis. The righting reflex was used as a clinical measure of hypnosis. The etomidate dose that had to be infused to reach the electroencephalographic endpoint was almost 40% lower (p < .01) in the hypovolemic animals than in the control animals. This difference could be attributed to a decrease in clearance (−20%; p = .06) and distribution volume (−30%; p < .01) of etomidate. Protein binding was similar in both groups. To investigate changes in end organ sensitivity during hypovolemia, the electroencephalographic effect-versus-effect-site concentration relationship was studied. The effect-plasma concentration relationship was biphasic, exhibiting profound hysteresis in both hypovolemic and control animals. Semiparametric minimization of this hysteresis revealed similar equilibrium half-lives in both groups, and the biphasic effect-concentration relationship was characterized nonparametrically by descriptors. With these descriptors, a slightly increased potency of etomidate during hemorrhage was observed. The concentration at the return of righting reflex was 16% (p < .05) lower in the hypovolemic animals. In conclusion, an increased hypnotic effect of etomidate was observed during hypovolemia that is mainly attributed to pharmacokinetic changes. Our data also suggest a small increase in central nervous system sensitivity for etomidate in hypovolemic animals.

Footnotes

  • Send reprint requests to: Dr. Peter De Paepe, Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium. E-mail:Peter.DePaepe{at}rug.ac.be

  • 1 This work was supported by University of Ghent Research Foundation Grants 011D0296 and 01104495.

  • Abbreviations:
    EEG
    electroencephalographic
    AMP
    amplitude per second
    MAP
    mean arterial blood pressure
    HR
    heart rate
    keo
    first-order rate equilibrium constant
    T1/2keo
    equilibrium half-life
    E0
    baseline effect
    Emax
    maximal activation of the electroencephalographic effect
    ECm
    concentration required to produce maximal electroencephalographic activation
    EC50
    concentration required to obtain 50% activation of the electroencephalographic effect
    ECb
    concentration required to produce the baseline effect between maximal electroencephalographic activation and maximal electroencephalographic inhibition
    • Received December 24, 1998.
    • Accepted April 15, 1999.
« Previous | Next Article »Table of Contents